• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Perrigo (NY: PRGO )

    25.90 +0.27 (+1.05%)
    Streaming Delayed Price Updated: 9:50 AM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Perrigo

    < Previous 1 2 3 4 Next >
    JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
    JP Morgan assesses the specialty pharma sector, highlighting robust fundamentals and new product excitement. Key focus on Teva, Organon, and Viatris. 
    Via Benzinga
    PRGO Stock Earnings: Perrigo Beats EPS, Misses Revenue for Q2 2024
    PRGO stock results show that Perrigo beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Abbott Labs (ABT) Stock Falls on Baby Formula Ruling. What to Know.
    ABT stock is in focus on ruling news. Abbott faced a suit last year over the closing of its Michigan plant resulting in a formula shortage. 
    Via InvestorPlace
    AbbVie Appeals To Supreme Court Over Attorney-Client Privilege In 'Long-Standing' AndroGel Case
    AbbVie petitions the U.S. Supreme Court to protect its corporate records, arguing a lower court ruling threatens attorney-client privilege. 
    Via Benzinga
    $20M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying
    Via Benzinga
    Earnings Scheduled For February 27, 2024
    Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
    Via Benzinga
    Perrigo Supports Customers through Tough Times, Supporting Shareholders through Changes
    Via Benzinga
    Preview: Perrigo's Earnings
    Via Benzinga
    Perrigo Supports Customers through Tough Times, Supporting Shareholders through Changes
    Via Benzinga
    Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    PRGO Stock Earnings: Perrigo Beats EPS, Misses Revenue for Q1 2024
    PRGO stock results show that Perrigo beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Disney To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
    Via Benzinga
    FDA Approves Over-the-Counter Birth Control Pill. Is the Pill Maker's Stock Set to Soar?
    Perrigo picked up a milestone regulatory win. 
    Via The Motley Fool
    CVS Health's Zero-Cost Coverage Paves Way For OTC Birth Control Access
    CVS Health expands coverage to include the first OTC birth control pill in the U.S., offering accessible contraception without prescription costs. Learn about this pivotal shift in reproductive... 
    Via Benzinga
    Hidden Gems: 3 Market Underdogs to Buy at Rock-Bottom Prices
    While these underdogs stocks might not be on everyone’s radar, they may offer surprisingly robust upside potential. 
    Via InvestorPlace
    Around $2M Bet On Tile Shop Holdings? Check Out These 4 Stocks Insiders Are Buying
    Although U.S. stocks closed higher on Thursday, there were a few notable insider trades. 
    Via Benzinga
    Stocks Mixed As Consumer Confidence Falls
    Stocks are mixed midday, after the most recent batch of economic data. 
    Via Talk Markets
    OTC Medicine Player Perrigo Outlines Three-Year Cost Saving Plan, Posts Mixed Q4 Earnings
    Perrigo Q4 2023 net sales reach $1.2 billion, up 0.1% YoY. Explore Project Energize for long-term growth. 
    Via Benzinga
    Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings. 
    Via Benzinga
    Insiders bet big on these turnaround stocks
    Insiders are buying Bally's, Delcath Systems and Perrigo while their shares are at historic lows and catalysts are ahead. 
    Via MarketBeat
    Topics Economy Initial Public Offering
    Exposures Interest Rates Securities Market
    Insiders Buying DENTSPLY SIRONA And 2 Other Stocks
    Although U.S. stocks closed lower on Monday, there were a few notable insider trades. 
    Via Benzinga
    $1.8M Bet On This Stock? Check Out These 3 Stocks Insiders Are Buying
    Although U.S. stocks closed slightly higher on Friday, there were a few notable insider trades. 
    Via Benzinga
    Personal Care Industry Poised For Growth: Analyst Initiates Coverage On These 3 Stocks
    Piper Sandler analyst Korinne Wolfmeyer initiated coverage on several personal care stocks, noting that amid the present economic conditions, consumers are becoming more discerning in their spending. 
    Via Benzinga
    Perrigo Cuts Annual Guidance, This OTC Drug Firm Also Reports Mixed Q3 Earnings
    Perrigo Company PLC (NYSE: PRGO) reported  
    Via Benzinga
    Cramer Says This AI Company 'Actually Lived Up To Their Hype': Stock Is Up 148% This Year
    On CNBC’s "Mad Money Lightning Round," Jim Cramer said Energy Transfer LP (NYSE: ET) is "good." 
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Earnings Scheduled For November 7, 2023
    Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. 
    Via Benzinga
    With a Big Catalyst in Hand, Is Perrigo Company a Buy?
    Regulators just ruled that one of its products can be sold over the counter. 
    Via The Motley Fool
    PRGO Stock Alert: Perrigo Climbs on Landmark FDA Birth Control Decision
    Perrigo (PRGO) stock is rising on Friday as investors react to the company's over-the-counter birth control pill getting FDA approval. 
    Via InvestorPlace
    First Birth Control Pill For OTC Use In US Lands FDA Approval
    Perrigo Company plc (NYSE: PRGO) shares are trading higher after the FDA approved the company's Opill, a progestin-only daily oral contraceptive for over-the-counter  
    Via Benzinga
    Perrigo Picks Former Bayer Executive As New CEO
    Perrigo Co PLC (NYSE: PRGO) disclosed the appointment of Patrick Lockwood-Taylor as its new President, CEO and member of the Board of Directors, 
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.